[ FUNDER ENTITY RECORD ]
AbbVie Inc.
VERIFIED SOURCE
ID: 001274 · abbvie-inc
M SOURCE NODE — CAPITAL PROVIDER
AbbVie Inc.
Operational Intelligence
[ M ]
Legal Name
AbbVie Inc.
HQ Jurisdiction
United States
Market Sector
Healthcare
Capital Capacity
$300K
Entity Intelligence Summary
AbbVie Inc. is a research-based global biopharmaceutical company committed to developing innovative therapies for complex health conditions. Based in Illinois, the firm focuses on immunology, oncology, and neuroscience to improve patient outcomes. AbbVie is a primary institutional funder of clinical trials and the acquisition of emerging pharmaceutical technologies.
Capital Deployment Log (Transactions)
| Date | Recipient | Type | Amount |
|---|---|---|---|
| 30/11/2023 | AbbVie ImmunoGen Platform | EQUITY | $10,100,000,000 |
| 06/12/2023 | Cerevel Therapeutics | EQUITY | $8,700,000,000 |
| 06/12/2023 | Cerevel Therapeutics | EQUITY | $8,700,000,000 |
| 30/11/2023 | ImmunoGen | EQUITY | $10,100,000,000 |